Literature DB >> 10751464

Body CT and oncologic imaging.

K D Hopper1, K Singapuri, A Finkel.   

Abstract

The most commonly used imaging modality in patients with cancer is computed tomography (CT). Whether to evaluate primary tumor or metastases to the neck, chest, abdomen, or pelvis, oncologic body CT has become invaluable to medical, gynecologic, and radiation oncologists. CT is the principal tool used to stage tumor, assess response, and guide radiation therapy. This review provides a discussion of how we optimize oncologic CT to best meet the needs of the patient with cancer.

Entities:  

Mesh:

Year:  2000        PMID: 10751464     DOI: 10.1148/radiology.215.1.r00ap1727

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

1.  F18-fluorodeoxyglucose-positron emission tomography and computed tomography is not accurate in preoperative staging of gastric cancer.

Authors:  Tae Kyung Ha; Yun Young Choi; Soon Young Song; Sung Joon Kwon
Journal:  J Korean Surg Soc       Date:  2011-08-03

2.  Automated method for detection and segmentation of liver metastatic lesions in follow-up CT examinations.

Authors:  Avi Ben-Cohen; Eyal Klang; Idit Diamant; Noa Rozendorn; Michal Marianne Amitai; Hayit Greenspan
Journal:  J Med Imaging (Bellingham)       Date:  2015-08-19

3.  Tumor burden analysis on computed tomography by automated liver and tumor segmentation.

Authors:  Marius George Linguraru; William J Richbourg; Jianfei Liu; Jeremy M Watt; Vivek Pamulapati; Shijun Wang; Ronald M Summers
Journal:  IEEE Trans Med Imaging       Date:  2012-08-07       Impact factor: 10.048

4.  [Comparison of unidimensional and bidimensional measurement to assess therapeutic response in the treatment of solid tumors].

Authors:  E A M Hauth; J Stattaus; M Forsting
Journal:  Radiologe       Date:  2007-07       Impact factor: 0.635

5.  Comparison of two-dimensional and three-dimensional iterative watershed segmentation methods in hepatic tumor volumetrics.

Authors:  Shonket Ray; Rosalie Hagge; Marijo Gillen; Miguel Cerejo; Shidrokh Shakeri; Laurel Beckett; Tamara Greasby; Ramsey D Badawi
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

6.  18F-fluorodeoxyglucose positron emission tomography in uterine carcinosarcoma.

Authors:  Kung-Chu Ho; Chyong-Huey Lai; Tzu-I Wu; Koon-Kwan Ng; Tzu-Chen Yen; Gigin Lin; Ting-Chang Chang; Chun-Chieh Wang; Swei Hsueh; Huei-Jean Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-19       Impact factor: 9.236

7.  Estimation of the tissue composition of the tumour mass in neuroblastoma using segmented CT images.

Authors:  F J Ayres; M K Zuffo; R M Rangayyan; G S Boag; V O Filho; M Valente
Journal:  Med Biol Eng Comput       Date:  2004-05       Impact factor: 2.602

8.  The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management.

Authors:  Anna C Pfannenberg; Karin Oechsle; Carsten Bokemeyer; Christian Kollmannsberger; Bernhard M Dohmen; Roland Bares; Jörg T Hartmann; Reinhard Vonthein; Claus D Claussen
Journal:  World J Urol       Date:  2004-01-21       Impact factor: 4.226

9.  Semi-automated measurement of hyperdense, hypodense and heterogeneous hepatic metastasis on standard MDCT slices. Comparison of semi-automated and manual measurement of RECIST and WHO criteria.

Authors:  Sebastian Keil; Florian F Behrendt; Sven Stanzel; Michael Sühling; Alexander Koch; Jhenee Bubenzer; Georg Mühlenbruch; Andreas H Mahnken; Rolf W Günther; Marco Das
Journal:  Eur Radiol       Date:  2008-06-04       Impact factor: 5.315

10.  Perfusion CT in patients with advanced bronchial carcinomas: a novel chance for characterization and treatment monitoring?

Authors:  F Kiessling; J Boese; C Corvinus; J R Ederle; I Zuna; S O Schoenberg; G Brix; A Schmähl; S Tuengerthal; F Herth; H U Kauczor; M Essig
Journal:  Eur Radiol       Date:  2004-03-17       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.